These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24987871)

  • 21. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival.
    Yan H; Qiu W; Koehne de Gonzalez AK; Wei JS; Tu M; Xi CH; Yang YR; Peng YP; Tsai WY; Remotti HE; Miao Y; Su GH
    Cancer Lett; 2019 Feb; 442():333-340. PubMed ID: 30447255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model.
    Peters MLB; Eckel A; Mueller PP; Tramontano AC; Weaver DT; Lietz A; Hur C; Kong CY; Pandharipande PV
    Pancreatology; 2018 Dec; 18(8):928-934. PubMed ID: 30143405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.
    Sugimoto M; Takahashi N; Farnell MB; Smyrk TC; Truty MJ; Nagorney DM; Smoot RL; Chari ST; Carter RE; Kendrick ML
    J Surg Oncol; 2019 Nov; 120(6):976-984. PubMed ID: 31452208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer.
    Wang W; Gao J; Man XH; Li ZS; Gong YF
    Oncol Rep; 2009 Jun; 21(6):1439-47. PubMed ID: 19424621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet to Lymphocyte Ratio Correlates With Carcinoma Progression in Pancreatic Intra Epithelial Neoplasia.
    Wagner D; Haybaeck J; Wienerroither V; Bajric T; Tomberger A; Schemmer P; Mischinger HJ; Kornprat P
    Anticancer Res; 2022 Mar; 42(3):1413-1419. PubMed ID: 35220234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
    Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
    Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
    Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
    Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of High-Grade Pancreatic Intraepithelial Neoplasia without Morphological Changes of the Main Pancreatic Duct over a Long Period: Importance for Close Follow-Up for Confirmation.
    Yamao K; Takenaka M; Nakai A; Omoto S; Kamata K; Minaga K; Miyata T; Imai H; Sakurai T; Watanabe T; Nishida N; Matsumoto I; Takeyama Y; Chikugo T; Kudo M
    Oncology; 2017; 93 Suppl 1():81-86. PubMed ID: 29258080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
    Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance of Necl-4 expression in pancreatic ductal adenocarcinoma.
    Kawanishi A; Hirabayashi K; Yamada M; Takanashi Y; Hadano A; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
    J Clin Pathol; 2017 Jul; 70(7):619-624. PubMed ID: 27980052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
    Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
    Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
    Gao H; Liu T; Wang G; Gao Y; Yin L; Peng Y; Lyu N; Zhang K; Gao W; Wu J; Jiang K; Wei J; Miao Y
    Langenbecks Arch Surg; 2019 Mar; 404(2):175-182. PubMed ID: 30826926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
    Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
    J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
    Andea A; Sarkar F; Adsay VN
    Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Chatterjee D; Katz MH; Rashid A; Wang H; Iuga AC; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Crane CH; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
    Am J Surg Pathol; 2012 Mar; 36(3):409-17. PubMed ID: 22301497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.